Market By Source Type, Methodology, Applications, Products & Services, End-users And Geography | Forecast 2019-2027
Triton Market Research has estimated the intraoperative neuromonitoring market in Europe to show growth in terms of revenue at 3.65% of CAGR in the forecast years between 2019 and 2027.
The countries examined in the Europe intraoperative neuromonitoring market are:
• Russia
• Spain
• Italy
• France
• Germany
• The United Kingdom
• Rest of Europe
Report scope can be customized per your requirements. Request For Customization
The growth of the European market for intraoperative neuromonitoring is being fueled by the growing number of surgeries (spinal, orthopedic) taking place in the European Union (EU). In Spain, total knee replacement procedures were more commonly performed than hip replacement procedures. These kinds of surgeries require intraoperative neuromonitoring devices for continuous monitoring so as to prevent any permanent damage to the nerves.
Also, the developed countries in the region, such as Italy, the UK, Spain and Germany, are witnessing a growth in demand for minimally invasive surgeries, which is another factor that has increased the adoption of IONM devices. Moreover, an increasing number of vendors in Europe are expanding their base in the region, which is fueling the growth of the market. Also, the rise in demand for ambulatory care services and awareness programs, as well as advancements in technology are pushing the growth of the IONM market.
Around 2 million people in the United Kingdom are estimated to be suffering from major neurological conditions, such as epilepsy Parkinson's disease. The rising incidences of these neurological diseases are a significant cause of concern that is fueling the growth of the UK intraoperative neuromonitoring market. Italy has the largest population of elderly people in the entire European region. It is estimated that, by the year 2050, over 15% of Italy’s total population would be above 80 years of age. This growth in the aging populace is driving the market growth in the country.
As a medical device company, inomed Medizintechnik GmbH deals with the research, development, engineering and production of intraoperative neuromonitoring products & services. The company facilitates the interdisciplinary exchange of knowledge and experience between medical engineers, researchers and users in hospitals for medical practice and outcomes. inomed Medizintechnik headquartered in Emmendingen, Germany.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
EUROPE INTRAOPERATIVE NEUROMONITORING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.
OUTSOURCED INTRAOPERATIVE NEUROMONITORING IS EXPECTED TO DOMINATE THE
MARKET
2.2.2.
EP IS A WIDELY USED METHODOLOGY OF INTRAOPERATIVE NEUROMONITORING
2.2.3.
SPINAL SURGERY IS THE LARGEST APPLICATION OF INTRAOPERATIVE NEUROMONITORING
2.2.4.
SERVICES SEGMENT IS GROWING AT A RAPID RATE
2.2.5.
AMBULATORY SURGICAL CENTERS (ASCs) ARE RAPIDLY ADOPTING INTRAOPERATIVE
NEUROMONITORING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1.
THREAT OF NEW ENTRANTS
2.3.2.
THREAT OF SUBSTITUTE
2.3.3.
BARGAINING POWER OF SUPPLIERS
2.3.4.
BARGAINING POWER OF BUYERS
2.3.5.
INTENSITY OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1.
INCREASING NEUROLOGICAL AND OTHER DISORDERS LEADING TO SURGERIES
2.6.2.
TECHNOLOGICAL ADVANCEMENT
2.6.3.
REDUCTION OF COMPLICATION DURING COMPLEX SURGERIES USING INTRAOPERATIVE
NEUROMONITORING
2.6.4.
INCREASING AGING POPULATION
2.7. MARKET RESTRAINTS
2.7.1.
HIGH COST OF IONM DEVICES AND SERVICES
2.7.2.
LACK OF SKILLED OPERATORS
2.8. MARKET OPPORTUNITIES
2.8.1.
RISE IN DEMAND FOR THE USE OF INTRAOPERATIVE NEUROMONITORING FOR
MINIMALLY INVASIVE SURGERIES
2.8.2.
DEVELOPMENT OF REMOTE INTRAOPERATIVE NEUROMONITORING
2.8.3.
EMERGENCE OF PORTABLE INTRAOPERATIVE NEUROMONITORING
2.9. MARKET CHALLENGES
2.9.1.
AVAILABILITY OF LESS COSTLY SUBSTITUTES
3.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY SOURCE TYPE
3.1. INSOURCED INTRAOPERATIVE NEUROMONITORING
3.2. OUTSOURCED INTRAOPERATIVE NEUROMONITORING
4.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY METHODOLOGY
4.1. EEG MONITORING
4.2. EMG MONITORING
4.3. EP MONITORING
4.3.1.
SEP MONITORING
4.3.2.
TCMEP MONITORING
4.3.3.
BAEP MONITORING
4.3.4.
VEP MONITORING
5.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY APPLICATIONS
5.1. SPINAL SURGERY
5.2. ENT SURGERY
5.3. NEUROSURGERY
5.4. VASCULAR SURGERY
5.5. ORTHOPEDIC SURGERY
5.6. OTHER SURGERIES
6.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY PRODUCTS &
SERVICES
6.1. SYSTEMS
6.2. ACCESSORIES
6.3. SERVICES
7.
INTRAOPERATIVE NEUROMONITORING MARKET OUTLOOK - BY END-USERS
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS (ASCs)
8.
INTRAOPERATIVE NEUROMONITORING MARKET - EUROPE
8.1. UNITED KINGDOM
8.2. GERMANY
8.3. FRANCE
8.4. SPAIN
8.5. ITALY
8.6. RUSSIA
8.7. REST OF EUROPE
9.
COMPETITIVE LANDSCAPE
9.1. ACCURATE NEUROMONITORING
9.2. INOMED MEDIZINTECHNIK GMBH
9.3. CADWELL
9.4. MOBERG RESEARCH, INC. (DAYONE MEDICAL LLC)
9.5. CNS NEUROMONITORING
9.6. COMPUTATIONAL DIAGNOSTICS
9.7. EMOTIV
9.8. INTRANERVE
9.9. MEDSURANT MONITORING
9.10.
MEDTRONIC
9.11.
NATUS MEDICAL
9.12.
SPECIALTYCARE
9.13.
NEUROMONITORING TECHNOLOGIES
9.14.
NEUROSENTINEL
9.15.
NIHON KOHDEN
9.16.
NUVASIVE
9.17.
CHECKPOINT SURGICAL
9.18.
ZYNEX
9.19.
ORIMTEC
10. RESEARCH METHODOLOGY & SCOPE
10.1.
RESEARCH SCOPE & DELIVERABLES
10.1.1.
OBJECTIVES OF STUDY
10.1.2.
SCOPE OF STUDY
10.2.
SOURCES OF DATA
10.2.1.
PRIMARY DATA SOURCES
10.2.2.
SECONDARY DATA SOURCES
10.3.
RESEARCH METHODOLOGY
10.3.1.
EVALUATION OF PROPOSED MARKET
10.3.2.
IDENTIFICATION OF DATA SOURCES
10.3.3.
ASSESSMENT OF MARKET DETERMINANTS
10.3.4.
DATA COLLECTION
10.3.5.
DATA VALIDATION & ANALYSIS
TABLE 1: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY,
2019-2027 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE,
2019-2027 (IN $ MILLION)
TABLE 4: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY METHODOLOGY,
2019-2027 (IN $ MILLION)
TABLE 5: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2019-2027 (IN $ MILLION)
TABLE 6: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS &
SERVICES, 2019-2027 (IN $ MILLION)
TABLE 7: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY END-USERS,
2019-2027 (IN $ MILLION)
TABLE 8: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY,
2019-2027 (IN $ MILLION)
FIGURE 1: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2018 & 2027 (IN %)
FIGURE 2: EUROPE OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 3: EUROPE EP MARKET, 2019-2027 (IN $ MILLION)
FIGURE 4: EUROPE SPINAL SURGERY MARKET, 2019-2027 (IN $ MILLION)
FIGURE 5: EUROPE SERVICES MARKET, 2019-2027 (IN $ MILLION)
FIGURE 6: EUROPE AMBULATORY SURGICAL CENTERS MARKET, 2019-2027 (IN $
MILLION)
FIGURE 7: PORTER’S FIVE FORCE ANALYSIS
FIGURE 8: MARKET ATTRACTIVENESS INDEX
FIGURE 9: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY INSOURCED
INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 10: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY OUTSOURCED
INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 11: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY EEG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 12: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY EMG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 13: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY EP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 14: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 15: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY TCMEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 16: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY BAEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 17: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY VEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 18: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SPINAL
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 19: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY ENT SURGERY,
2019-2027 (IN $ MILLION)
FIGURE 20: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY
NEUROSURGERY, 2019-2027 (IN $ MILLION)
FIGURE 21: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY VASCULAR
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 22: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY ORTHOPEDIC
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 23: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY OTHER
SURGERIES, 2019-2027 (IN $ MILLION)
FIGURE 24: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SYSTEMS, 2019-2027
(IN $ MILLION)
FIGURE 25: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY ACCESSORIES,
2019-2027 (IN $ MILLION)
FIGURE 26: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY SERVICES,
2019-2027 (IN $ MILLION)
FIGURE 27: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY HOSPITALS,
2019-2027 (IN $ MILLION)
FIGURE 28: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, BY AMBULATORY
SURGICAL CENTERS (ASCs), 2019-2027 (IN $ MILLION)
FIGURE 29: EUROPE INTRAOPERATIVE NEUROMONITORING MARKET, REGIONAL
OUTLOOK, 2018 & 2027 (IN %)
FIGURE 30: UNITED KINGDOM INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 31: GERMANY INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 32: FRANCE INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 33: SPAIN INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 34: ITALY INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 35: RUSSIA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 36: REST OF EUROPE INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)